WuXi STA scientists and partner Merck recently published this OPRD paper discussing how photochemistry and continuous processing technology (flow chemistry) enabled the development of robust and greener commercial-scale manufacturing process for the novel oncology therapy Belzutifan (MK-6482).
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.